Cargando…
Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era
SIMPLE SUMMARY: Systemic chemotherapies have revolutionized therapeutic paradigms for hepatocellular carcinoma (HCC) over the past decade. Various regimens have progressively become standard-of-care in clinical practice. However, there are no reports regarding the impact of multiple sequential thera...
Autores principales: | Nakamura, Yoshiko, Hirooka, Masashi, Hiraoka, Atsushi, Koizumi, Yohei, Yano, Ryo, Morita, Makoto, Okazaki, Yuki, Imai, Yusuke, Ohama, Hideko, Hirooka, Kana, Watanabe, Takao, Tada, Fujimasa, Yoshida, Osamu, Tokumoto, Yoshio, Abe, Masanori, Hiasa, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650854/ https://www.ncbi.nlm.nih.gov/pubmed/37958471 http://dx.doi.org/10.3390/cancers15215298 |
Ejemplares similares
-
Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites
por: Hirooka, Masashi, et al.
Publicado: (2022) -
Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease
por: Hirooka, Masashi, et al.
Publicado: (2017) -
Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation
por: Imai, Yusuke, et al.
Publicado: (2019) -
Radiofrequency Ablation Covering the Entire Tumor Blood Drainage Area Improves Survival in Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2021) -
Usefulness of a New Three-Dimensional Simulator System for Radiofrequency Ablation
por: Hirooka, Masashi, et al.
Publicado: (2016)